bpc 157 compounded pharmacy Exciting news for peptides coming out of today's committee hearing! The FDA Compounding Advisory Committee voted 8-6 to recommend adding BPC-157 to the 503A Bulks List for use in compounding for BPC-157 – Lethbridge Peptides (PC)

Gastric activity and gut peptides in patients with functional dyspepsia: postprandial distress syndrome versus epigastric pain syndrome

At its July 23 and 24 meetings, the committee will consider whether the seven peptides should be added to the 503A Bulks List

When REDEFINE 4 results are published, they will provide the first and only direct comparison between these two treatments using the same population, the same endpoints, and the same measurement protocols

Swirl gently until the cake fully dissolves into a clear, colourless solution

New developments and future directions in understanding locus coeruleusNorepinephrine (LC-NE) function